754P Ibrutinib (ibr) in Combination with Paclitaxel (pac) Has Activity in Patients (pts) with Advanced Urothelial Carcinoma (auc): Final Analysis of a Phase Ib/II Study
ANNALS OF ONCOLOGY(2020)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined